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Abstract
Influenza virus (IV) infections represent a very serious public health problem. At present, no established biomarkers exist 
to support diagnosis for respiratory viral infections and more importantly for severe IV disease. Studies in animal models 
are extremely important to understand the biological, genetic, and environmental factors that contribute to severe IV disease 
and to validate biomarker candidates from human studies. However, mouse human cross-species comparisons are often 
compromised by the fact that animal studies concentrate on the infected lungs, whereas in humans almost all studies use 
peripheral blood from patients. In addition, human studies do not consider genetic background as variable although human 
populations are genetically very diverse. Therefore, in this study, we performed a cross-species gene expression study of the 
peripheral blood from human patients and from the highly genetically diverse Collaborative Cross (CC) mouse population 
after IV infection. Our results demonstrate that changes of gene expression in individual genes are highly similar in mice 
and humans. The top-regulated genes in humans were also differentially regulated in mice. We conclude that the mouse 
is a highly valuable in vivo model system to validate and to discover gene candidates which can be used as biomarkers in 
humans. Furthermore, mouse studies allow confirmation of findings in humans in a well-controlled experimental system 
adding enormous value to the understanding of expression and function of human candidate genes.
Introduction
Each year, about 500 million people are infected worldwide 
by the influenza virus (IV) type A and B, of which about 
500,000 die (Fauci 2006). For the diagnosis and treatment 
of severe IV infections, it is important to determine the 
infection status and the status (timing and quality) of the 
host response. Detection of virus in nasal swaps by rapid 
influenza diagnostic tests or by polymerase chain reaction 
tests is the first step to diagnose an IV infection. However, 
detection of virus per se in these swabs is not very informa-
tive for treatment decisions. It does not provide information 
on the level of virus replication in the lung, which is most 
relevant for severe IV disease nor does it allow clinicians 
to evaluate the degree or quality of the host response. For 
example, hypoxia is a hallmark for severe IV infections, but 
it represents a very late stage marker of disease. Therefore, 
a significant need exists for earlier biomarkers that have 
prognostic value for predicting the development of severe 
IV disease. Furthermore, whether an individual is suffering 
from viral or bacterial pneumonia has important implica-
tions for treatment; however, it is often difficult to differ-
entiate between the two types of pneumonia using current 
diagnostic methods (Parnell et al. 2012). Therefore, more 
and better biomarkers are needed that allow diagnosis of 
disease driven by IV infection, bacterial co-infection, or the 
infection-induced host response.
Transcriptional or proteomic signatures hold promise 
for identifying early prognostic biomarkers that can be 
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used to predict patient outcome during IV infection, and 
we and others have performed transcriptome and proteome 
studies to identify virus-specific signatures in IV-infected 
patients (Herberg et al. 2013; Huang et al. 2011; Ioannidis 
et al. 2012; Marion et al. 2016; Parnell et al. 2012; Ramilo 
et al. 2007; Suarez et al. 2015; Tang et al. 2017; Thach et al. 
2005; Tsalik et al. 2016; Woods et al. 2013; Zaas et al. 2009; 
Zhai et al. 2015). Now, there is an urgent need to validate 
these markers and to understand the biological context of 
their expression, so that these findings can be applied to 
the clinic. However, due to difficulties associated with per-
forming mechanistic validation studies in humans, it will 
be important to compare findings in well-controlled animal 
models to the results in humans.
The mouse model has been instrumental in evaluating 
the virulence and the pathogenic mechanisms of IV infec-
tions and the associated host response (e.g., Kollmus et al. 
2014). Studies in genetically well-defined mouse popula-
tions have shown the importance of genetic background for 
susceptibility and resistance (Boon et al. 2009; Ferris et al. 
2013; Leist et al. 2016; Srivastava et al. 2009; Trammell 
et al. 2012). In particular, the highly genetically diverse Col-
laborative Cross (CC) genetic reference population (GRP) 
represents an ideal tool to study phenotypic diversity which 
is caused by genotypic variations (Collaborative Cross Con-
sortium 2012). The CC is derived from eight genetically 
diverse founder strains, which were intercrossed and then 
inbred to produce a reproducible population of recombinant 
inbred (RI) strains where each strain is a genetic mosaic 
of the original eight founder strains (Collaborative Cross 
Consortium 2012). Importantly, the CC strains exhibit 
more than 40 million single-nucleotide polymorphisms and 
many insertions, deletions, and structural variations, which 
is comparable to the genetic diversity in human populations 
(Collaborative Cross Consortium 2012). Furthermore, this 
diversity is evenly distributed across the genomes of the CC 
at the population level. In addition, the CC represents an 
ideal GRP for the mapping of quantitative traits to identify 
genetic variations that contribute to the host response to IV 
infections which may be highly relevant for severe course of 
IV infections in humans (Collaborative Cross Consortium 
2012; van Sluijs et al. 2017).
Biomarker studies in humans are mainly limited to the 
analysis of readily available body fluids. For respiratory 
infections, nasal swabs or blood is the most preferable source 
for diagnosis. For severe infections, blood is more preferable 
than nasal swabs since the critical infection is taking place 
in the lung. Therefore, almost all current human studies have 
analyzed the blood. On the other hand, almost all studies in 
mice investigate the infected organ (lung for IV) because 
they aim to understand the biological mechanisms at the 
site of infection. This raises an important caveat; compari-
sons between responses in IV-infected mouse lungs are of 
limited value to validate biomarkers that have been identified 
in human peripheral blood or vice versa.
The value of extending mouse studies to humans was fur-
ther called into question by a study that compared inflam-
matory responses after burns, trauma, and endotoxemia in 
mouse and human blood (Seok et al. 2013). In this study, 
which has received a significant amount of attention in the 
media, the authors concluded that the changes in the tran-
scriptome observed in human patients could not be replicated 
in mice. However, these conclusions have been challenged 
later (Takao and Miyakawa 2014). It is also very important 
to note that Seok et al. used only a single inbred mouse 
strain for their model, C57BL/6J, while the human samples 
came from patients with different genetic backgrounds (Seok 
et al. 2013). Therefore, to truly assess whether mouse mod-
els can be used to identify and validate biomarkers that are 
relevant to human infectious diseases, it will be important 
to carefully compare responses in the appropriate tissues, 
in this case the blood, while also accounting for the impact 
of host genetic variation. Furthermore, since these types of 
responses are likely to be specific for individual pathogens 
or classes of pathogens, it will also be important to extend 
this analysis to viral pathogens such as IV.
Here, we analyzed the peripheral blood transcriptome as 
an indicator of the host response after IV infection in dif-
ferent CC strains and compared it to blood transcriptome 
changes in human patients infected with IV. We show that 
the global responses are heterogeneous both in mice and 
humans and that in the mouse model, genetic background 
plays an important role for the severity of IV disease and 
that it strongly influences the transcriptional response. Fur-
thermore, at the single gene level, responses in mouse mod-
els and human patients are very similar or even identical. 
In conclusion, our results support the use of experimental 
mouse models to validate findings in human IV studies, to 
suggest additional biomarkers, and to better understand the 
biology and environmental factors that drive disease severity 
and transcriptional responses in the host.
Results
Highly variable phenotype in the host response 
to IV in different CC strains
Here, we compared the host transcriptome responses after 
IV infection in the blood of human patients and experi-
mental mouse models. Since humans are genetically 
diverse, we also chose to compare these responses to the 
CC due to the high levels of genetic diversity present in 
this genetically complex mouse genetic reference popula-
tion. In this study, we chose eleven CC strains that, at 
the time, were readily available from the resource at the 
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University of North Carolina (http://csbio .unc.edu/CCsta 
tus/index .py). These eleven CC strains were highly inbred 
(4–12% at residual heterozygosity). Nine carried genomic 
regions from all eight founder strains. Three strains, 
CC019, CC041, and CC051, contained genomic regions 
of six founder strains. Together, the eleven strains exhib-
ited a good representation of all eight founder haplotypes 
across the genome (Fig. S1).
Female CC mice (n = 8–16) at the age of 8–12 weeks 
were infected with 10 focus forming units (FFU) of mouse-
adapted H3N2 virus. Changes in body weight (BW) and 
survival were followed over the next 14 days post infection 
(pi). As shown in Fig. 1a, large variation of BW loss and 
survival ratios was observed across the 11 strains. ANOVA 
revealed a significant effect of strain and the interaction of 
strain and day (repeated measures using data from day 0 to 
day 5 when all mice from all strains were still alive, model: 
BW ~ strain × day). Broad sense heritability was 62% for 
the day 5 BW values. Two strains, CC001 and CC005, 
were resistant to the infection: all infected mice survived 
(Fig. 1b). All other strains exhibited a severe phenotype 
(> 15% of infected mice died). We refer to these strains as 
‘severe’ strains in this manuscript. Table 1 describes the 
CC strains, their susceptibility category, and group sizes 
used in our study.
These results demonstrate that the large genetic diversity 
of CC strains results in highly diverse IV response pheno-
types. They also revealed that susceptibility and resistance 
after IV infection is a trait that is strongly influenced by 
genetic background. Humans also exhibit high levels of vari-
ation in susceptibility and response to infections. Therefore, 
we hypothesize that a major part of this variation is caused 
by genetic variation, and that sets of CC strains should better 
represent human IV infectious disease than studies using a 
single inbred mouse strain.
Global blood transcriptome response in mice 
and human after IV infection leads to similar 
separation/overlap between infected and control 
groups
Based on the variation in IV-induced disease observed in 
the CC strains, we compared responses to IV infections in 
mouse and human by analyzing transcriptome changes in 
whole blood from infected CC strains and human patients. 
For this, we collected peripheral blood from infected CC 
mice at days 3, 5, and 8 pi and performed expression array 
Fig. 1  Highly divergent changes 
in body weight and survival 
rates of CC strains after infec-
tion with influenza A H3N2 
virus. Eight to twelve weeks old 
female mice of the indicated 
CC strains were infected intra-
nasally with 10 FFU of the 
mouse-adapted influenza H3N2 
virus (A/HK/01/68). a Changes 
in body weight and b survival 
were monitored for 14 days pi. 
Mice that exhibited a weight 
loss of more than 30% relative 
to their starting weight were 
euthanized and scored as dead
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studies. This experimental setting is very important for 
cross-species comparisons, since studies in humans mainly 
use peripheral blood, and we found that changes in transcrip-
tomes were very different in lung and blood (Fig. S2, blood 
data are from this study, lung data are taken from Leist et al. 
2016). For example, many more DEGs were observed in 
lung compared to blood which is most likely due to the fact 
that the lung is the primary organ of infection and that the 
cell composition is much more complex in lung (lung tissue 
plus immune cell infiltrates) than blood. In addition, mice 
that were mock infected with PBS served as controls, which 
allowed us to exclude the influence of the infection proce-
dure at early time points after infection on gene expression 
changes (Preusse et al. 2013). This contrasts with human 
studies where patients are already symptomatic at the time 
of analysis in field studies.
The results were then compared to transcriptome changes 
in peripheral blood of human patients from data sets that 
we downloaded from public databases. We chose three 
publically available human data sets from the GEO gene 
expression database (http://www.ncbi.nlm.nih.gov/geo/). 
The first study was composed of human volunteers infected 
with H1N1 and H3N2 virus (GSE52428 Woods et al. 2013), 
a second field study compared healthy controls with IV-
infected patients (GSE68310 Zhai et al. 2015), and the third 
data set is derived from our own study (GSE82050 Tang 
et al. 2017). These data sets were chosen because they were 
publically available and each of them had a reasonably large 
group size of infected patients and controls (n ≥ 15 for each). 
GSE52428 represents a study with controlled infections of 
human volunteers and GSE68310 has analyzed the cur-
rently largest group of IV-infected patients (n > 45 depend-
ing on the day pi). Both data sets followed transcriptome 
changes over time with comparable times to our mouse data 
(day 2–day 4.5 pi for GSE52428 and days 2, 5, and 8 pi 
for GSE68310). Furthermore, our own study (GSE82050) 
identified IFI27 as one of the most strongly up-regulated 
genes, and we suggested it as a marker for IV and other 
respiratory viral infections (Tang et al. 2017).
Here, we aimed to compare mouse to human host 
responses at early time points after infection since these are 
most relevant for diagnosis and treatment decisions in human 
patients with the risk for severe infections. Therefore, we 
selected only the relevant time points (until day 8 pi) from 
the above data sets. From the GSE52428 data set, baseline 
values (before infection challenge) was selected as control 
group, and 45.5 h pi (about day 2) and 93.5 h pi (about day 
4) for the infected groups. Also, we only selected samples 
from infected participants that showed symptoms. This data 
set was named Woods_13. For GSE68310, we selected only 
the samples that were derived from IV-infected patients and 
from early time points after infection. Baseline (taken pro-
spectively at enrollment before occurrence of symptoms) 
values were selected as controls and day 0, day 2, and day 
4 (day 0: first visit within 48 h of occurrence of symptoms) 
as infected groups. This data set was named Zhai_15. From 
GSE82050, the entire data set was used and named Tang_17. 
Table 2 provides a description of all data sets used in our 
study with the respective time points and group sizes and 
Tables S1–S4 list all samples.
First, we performed principle component analysis (PCA) 
for controls and infected groups from human and mouse 
to compare the global changes in gene expression after 
infection. The analysis was performed with the top 3000 
most variant probe sets to avoid too high noise by low level 
expressed transcripts. Infected and control groups separated 
in the PCA in all human data sets (Fig. 2a, b, c) as well 
as for the mouse CC strains (Fig. 3a). However, there was 
considerable overlap between infected and control groups 
in all data sets. In addition, there was no clear distinction of 
groups according to their days pi/collection in any data set. 
In humans, the factors that may cause the overlap between 
Table 1  Classification of strains 
and number of mice per group CC strain Category Number of mice for
BW & sur-
vival
Number of 
mice for
Mock_day3
Number of 
mice for
Day_3
Number of 
mice for
Day_5
Number of 
mice for
Day_8
CC001 Resistant 16 3 3 3 4
CC002 Severe 12 3 3 3 3
CC003 Severe 11 3 3 3 5
CC004 Severe 8 3 3 3 0
CC005 Resistant 10 3 3 3 3
CC006 Severe 11 3 3 3 0
CC019 Severe 10 3 3 5 3
CC036 Severe 12 3 3 3 0
CC041 Severe 13 4 4 3 3
CC051 Severe 12 3 3 3 3
CC053 Severe 11 3 3 3 0
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infected and control groups are not known. They may rep-
resent differences in the host response because of vaccine 
status, infection dose, comorbidities, etc. However, also 
in the well-controlled mouse studies the overlap between 
infected and control groups was considerable. In the mouse 
data set, it was possible to stratify groups with respect to 
their genetic background. This stratification showed that 
different CC strains differ largely in their global transcrip-
tome response to IV infections (Fig. 3b, c). For example, 
the resistant strain CC005 exhibited hardly any change in 
gene expression and the response was back to control levels 
at day 5 (Fig. 3b). On the other hand, the highly susceptible 
CC strain CC004 exhibited a very strong overall response 
to the infection (Fig. 3c). The PCA showed that day 3 and 
day 5 pi responses differ largely from baseline responses for 
this strain.
In conclusion, variation of the host response between case 
and control groups at the transcriptome level was similarly 
heterogeneous in mice as in humans. However, in our well-
controlled experimental mouse model, a large portion of this 
variation was due to genetic diversity. It was shown before 
that genetic background in CC strains and CC founders (Fer-
ris et al. 2013; Leist et al. 2016) strongly influences virus 
replication in the lung. Our observations in mice suggest that 
genetic variation also contributes significantly to heteroge-
neity of susceptibility and host response in humans.
Many infection‑related differentially expressed 
genes are identical between mouse and human
Next, we identified differentially expressed genes (DEGs) 
between infected and control groups in human and mouse 
data sets to determine the overlaps between and within a 
species. In the human data sets, we combined the various 
time points after infection to a single infected group and 
then contrasted healthy controls to infected patients. For 
the mouse, we also combined the different days pi to a sin-
gle infected group and mock-infected animals were used 
as controls. Since there were no severe cases (deaths) in 
humans, we performed two separate comparisons in CC 
mice—between infected resistant strains and all controls and 
between infected severe strains and all controls. Differen-
tially expressed genes (note that some genes are represented 
by multiple probe sets which were analyzed separately) were 
defined to exhibit > 1.5-fold difference in expression value 
(delta  log2 > 0.585) between infected and controls and a false 
discovery rate (using BH for multiple testing correction) of 
FDR < 10%. Based on the outcome of the infections in mice, 
we distinguished resistant and severe strains (see above). 
Table 3 shows the number of differentially expressed probe 
sets for each pairwise comparison of infected versus con-
trols. Detailed lists for all DEGs can be found in the sup-
plementary data (Tables S5–S10). In the human data sets, 
more down-regulated than up-regulated DEGs were found. 
This was the inverse for the mouse comparisons. Also in the 
mouse studies, many more DEGs were detected compared to 
humans. The reason for this may be that mouse experiments 
are well-controlled and thereby are less prone to noise from 
uncontrolled confounding factors as in humans.
We then determined the overlap between the DEGs 
from all of the above comparisons, (Fig. 4a: DEGs from 
all human data sets with DEGs from mouse resistant 
versus control; Fig. 4b: DEGs from all human data sets 
with DEGs from mouse severe versus control). 22 DEGs 
(BST2, DHX58, HERC6, IFI27, IFI35, IFI44, IFIH1, 
IFIT1, IFIT2, IFIT3, IFITM1, IRF7, ISG15, MX1, OAS2, 
OAS3, PLAC8, RSAD2, RTP4, USP18, XAF1, ZBP1) 
overlapped between the human data sets and the mouse 
resistant versus controls and 26 DEGs (BST2, DHX58, 
EIF2AK2, IFI27, IFI35, IFI44, IFIH1, IFIT1, IFIT2, 
IFIT3, IFITM1, IRF7, ISG15, LY6E, MX1, OAS2, OAS3, 
PLAC8, PLSCR1, RTP4, SAT1, SERPING1, TAP1, 
USP18) overlapped between the human data sets and the 
mouse severe versus controls DEGs. Many of these over-
lapping DEGs belonged to the interferon pathway which 
is activated after viral infection. Each of the mouse and 
human data sets had a unique number of DEGs that was 
not shared with any other group. These unique genes are 
Table 2  Description of data sets for PCA, DEGs, and boxplot analyses
a Days of analysis (after infection for Woods_13, for day after hospital admission for Zhai_15 and Tang_17)
b Note that not for all 49 patients data were available for all days (baseline: 48, day 2: 49, day 4: 45, day 6: 46)
c Day 8 was only analyzed when the survival rate for this strain was higher than 60%
Data set name Reference GEO data 
set
Selected time points 
combined to infected 
group
Number of indi-
viduals in infected 
group
Selected 
for control 
groups
Number of indi-
viduals in control 
group
References
Woods_13 GSE53248 45.5 h, 93.5 ha 20 pre-ch-basl 20 Woods et al. (2013)
Zhai_15 GSE68310 Days 2, 4,  6a 49b Baseline 48 Zhai et al. (2015)
Tang_17 GSE82050 Day  1a 24 hlty_ctr 15 Tang et al. (2017)
CC strains GSE110384 Days 3, 5,  8c 127; 11 strains Mock 34 This publication
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not enriched for any particular annotation across all data 
sets using the R package clusterProfiler (Yu et al. 2012), 
suggesting that these unique differences between cohorts 
are random. Only the CC and Tang_17 shared the anno-
tations “Neutrophil degranulation” and “Antigen pro-
cessing-Cross presentation” for the unique groups. Most 
remarkably, this set of unique DEGs in CC mice was not 
specifically higher compared to the human data sets (80% 
for CC (unique DEGs divided by total number of DEGs), 
62% for Woods_13, 42% for Zhai_15, 81% for Tang_17 
in Fig. 4a). Also, the overlap of DEGs between Tang_17 
and CC mice (55 DEGs) was similarly large as the over-
lap between Tang_17 and Woods_13 (47 DEGs; Fig. 4a). 
Based on these results, we conclude that, at the global 
level, differences in the identification of DEGs between 
various human studies are mainly caused by differences 
Fig. 2  Principle component analysis of gene expression values from 
blood of patients infected with influenza virus. Principle component 
analysis (PCA) revealed separate grouping of controls versus infected 
patients and mice. Black: controls, red: infected; days pi are indicated 
by symbols. a Woods_13, b Zhai_15, (C) Tang_17. cntrl controls, inf 
infected, pre_ch_basal pre-challenge basal, Flu_pos infected, hlty_ctr 
healthy controls. Days pi/admission are indicated by symbols. cntrl 
healthy controls, hlty_ctr healthy controls, inf infected individuals, 
Flu_pos infected individuals
Fig. 3  Principle component analysis of gene expression values 
from blood of CC mouse strains after infection with influenza virus. 
Principle component analysis (PCA) revealed separate grouping of 
mock controls versus infected mice. a Black: mock-infected controls 
(mock), red: infected mice (infctd); days pi are indicated by symbols. 
b and c The same PCA as in (a) highlighting a single CC strain in 
red; days pi are indicated by symbols. cd3 mock-treated controls at 3 
days after treatment, d3 day3 pi, d5 day 5 pi, d8 day 8 pi
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between their designs (cohorts, time points pi, technical 
platforms, etc.) and not because of species differences. 
The overlaps observed for human DEGs between different 
studies were not higher than between mouse and human.
Cross‑species comparison of the expression 
of individual DEGs reveals similar changes in mice 
and human
A major goal in human studies is to identify molecular sig-
natures that can be used as biomarkers for viral versus bac-
terial infection or severe versus moderate infections. Such 
biomarkers may be genes that change expression levels as 
a function of infection (yes/no), pathogen (viral/bacterial), 
or disease severity (moderate/severe). Therefore, we com-
pared changes in the expression of individual genes between 
human and mouse to determine how well the mouse model 
mimics human responses at the single gene level. For this, 
we performed a comparative analysis of all 26 overlapping 
DEGs from Fig. 4b (Fig. 5-1 to -26). For the human data 
sets, we combined the indicated days pi to a single infected 
group as described above. For the mouse, we combined all 
resistant strains into a single group, and the severe strains to 
a second group. Mock-treated animals were used as controls.
Differences in expression between infected and healthy 
controls in humans were significant for all overlap DEGs. 
Similarly, all differences between mice with a severe phe-
notype and mock controls were significant. However, for 
some genes (Ly6e, Plscr1, Sat1, Serping1, Tap1), no sig-
nificant difference between mice from the resistant group 
and controls were observed in the mouse studies, whereas 
differences between the severe group and controls were sig-
nificantly different. These results demonstrate that at the 
single gene level, results from mouse and human are highly 
comparable. In addition, mouse studies revealed differences 
between strains that exhibited severe influenza disease ver-
sus resistant strains. The differences represent valuable can-
didates to validate in humans with severe versus moderate 
infection outcomes. Thus, the mouse is a well-suited model 
for human responses to IV infections at the transcriptome 
level when the same tissues (blood) in both species and 
genetically variant mouse populations are used.
Temporal changes of single differentially expressed 
genes in mice and human are very similar
A big advantage of controlled animal infection experiments 
is the possibility to study defined time points after infection 
in biological replicates, including individuals of the same 
sex, age, and genetic background. In human studies follow-
ing natural infection, these variables are often not controlled 
and at best the time after onset of symptoms is recorded. 
The study by Woods et al. is an exception. This study ana-
lyzed the blood of infected volunteers from 5 to 165.5 h after 
infection. Thus, this is one of the very few well-controlled 
analyses with respect to different time points pi. In our anal-
ysis, we included only the time points until 108 h for this 
data set since the later time points had only samples from a 
Table 3  Number of up- and down-regulated differentially expressed 
probe sets between infected and control groups
Comparison Dataset DEG up-
regulated
DEG 
down-
regulated
Woods_13 Human 138 302
Zhai_15 Human 23 121
Tang_17 Human 195 1144
CC strains resistant versus controls Mouse 439 192
CC strains severe versus controls Mouse 877 507
CC strains severe versus resistant Mouse 904 1122
Fig. 4  VENN diagram of differentially expressed genes for mouse 
and human data sets. VENN diagram of differentially expressed 
genes (DEGs) revealed similar overlaps between human cohorts and 
between mouse and human data sets. a DEGs from human compari-
sons of infected versus controls, and mouse DEGs from the com-
parison between controls (mock-infected mice from all strains) and 
infected mice from resistant CC strains (CC_resis_ctr). b DEGs from 
human comparisons of infected versus controls (datasets indicated by 
names Tang, Woods, Zhai, respectively), and mouse CC DEGs of the 
comparison between mock and infected mice from severe CC strains 
(CC_ svre _ctr)
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single person. Also, we only analyzed symptomatic patients. 
The study by Zhai et al. recorded also the temporal change in 
gene expression. In this case, samples were collected from 
days 0 (first visit within 48 h of occurrence of symptoms) to 
21 days after the first visit and also post-seasonal samples 
after complete recovery (‘spring’). For the Zhai data set, we 
included all time points from the study. Please note that both 
human data sets are larger than the ones described above 
and in Table 1 since they contain additional time points. 
As an example, we performed an analysis of the kinetics 
of gene expression changes for genes IFI27 and IRF7 in 
humans and mice. IFI27, an interferon-regulated gene, had 
been proposed as potential marker to distinguish respiratory 
viral from bacterial infections (Tang et al. 2017). IFI27 was 
the top DEG in humans when contrasting expression levels 
in controls versus infected patients in all three human data 
sets (this study). IRF7, an interferon-regulating transcription 
factor, is an important host gene for the successful defense 
Fig. 5  Changes in the expres-
sion levels of 26 overlapping 
differentially expressed genes 
in human and mouse data 
sets. Boxplots for individual 
expression values of normal-
ized  log2-transformed signal 
intensities in the blood of 
human patients and mice for 
infected individuals and con-
trols are shown. a Woods_2013, 
b Zhai_15, c Tang_17, d CC 
mouse strains. cntrl controls, inf 
infected, mouse: cntrl: mock-
treated controls, resist resistant 
mouse strains after infection, 
sevre: severe mouse strains 
after infection. Significant p 
values of pairwise comparisons 
between controls and respective 
infected groups are indicated as 
*p < 0.05; **p < 0.01
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Fig. 5  (continued)
to IV infections. Mice with a knockout in this gene are more 
susceptible to IV infections (Hatesuer et al. 2017). IRF7 was 
significantly up-regulated in both human and mouse blood 
after infection (this study).
Our analyses showed that in humans, IFI27 expression 
steadily increased from 53 h (day 6.6) pi until 108.5 h (day 
13.6) pi in the Woods data set reaching the highest level 
at 108.5 h (Fig. 6a). In the Zhai data set, IFI27 expres-
sion increased from day 0 to day 2 and then declined on 
day 4 and day 6 (Fig. 6b). Expression levels were back 
to baseline levels on day 21 and post-seasonal (Fig. 6b). 
The differences in the timings between the two datasets 
are due to different definitions of the time post infections. 
Woods counts the actual time after infection, whereas Zhai 
designates the day when patients come into the clinic with 
symptoms as day 0. In mice, individual CC strains were 
analyzed and for this comparison, we calculated the mean 
difference at each day with respect to mock controls. The 
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expression kinetic in the CC mice strains was very similar 
to that in humans. Expression of Ifi27 increased at day 3 
pi and then declined on day 5 pi in most strains (Fig. 6c). 
However, individual differences for different strains could 
be observed. For example, CC001 still had high levels at 
day 8, whereas CC006 had lower levels already on day 3 
and baseline levels on day 5. Also, other strains exhibited 
an increase in expression from day 3 to day 5. Visuali-
zation of individual expression values demonstrated that 
gene expression levels were highly reproducible within 
a given mouse strain and that the variation is not due to 
experimental variation (Fig. S3a). Of note, the baseline 
levels (mock-treated) were already different between CC 
mouse strains and profiles were different between strains 
although the general trends were identical (Fig. S3a). 
The results in the mouse model demonstrate again that 
genetic background is a major factor causing individual 
differences.
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Expression analyses of IRF7 showed similar results 
(Fig. 7c). It was up-regulated early in infection, increased 
steadily, and then declined at a later time point when the 
immune response in mice switches from innate to adap-
tive as previously described in mice (Pommerenke et al. 
2012). Here again, the mouse model reproduced very well 
the general kinetics of gene expression that was observed 
in humans—with differences between individual strains 
(Fig. 7c, Fig. S3b). It is worth noting that in the Woods 
data set, expression of IFI27 and IRF7 separated into two 
different groups. One group showed an up-regulation of 
expression, and the other did not exhibit an up-regulation 
although volunteers were infected under very controlled 
conditions. The reason for this separation is unclear.
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Materials and methods
Ethics statement
All experiments in mice were approved by an external 
committee according to the national guidelines of the ani-
mal welfare law in Germany (BGBl. I S. 1206, 1313 and 
BGBl. I S. 1934). The protocol used in these experiments 
has been reviewed by an ethics committee and approved by 
the relevant authority, the ‘Niedersächsisches Landesamt 
für Verbraucherschutz und Lebensmittelsicherheit, Olden-
burg, Germany’ (Permit Numbers: 33.9.42502-04-051/09 
and 3392 42502-04-13/1234).
Viruses
A/Hong Kong/01/68 (H3N2) was originally obtained from 
Otto Haller, University of Freiburg (Haller et al. 1979). 
Fig. 5  (continued)
458 H. Kollmus et al.
1 3
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All viruses were propagated in the chorio-allantoic cav-
ity of 10-day-old SPF (specific pathogen-free) embryo-
nated chicken eggs (Charles River Laboratories, Ger-
many) for 48 h at 37 °C, as described previously (Wilk 
and Schughart 2012), aliquoted, and stored at − 80 °C. The 
titer of the stock viruses was determined by focus form-
ing unit assay (FFU/ml) in Madin-Darby Canine Kidney 
II (MDCK) cells (ATCC) as described previously (Wilk 
and Schughart 2012). Viral RNA was extracted using the 
QIAamp Viral RNA Extraction Kit (Qiagen) according to 
the manufacturer’s instructions and submitted for sequenc-
ing by Next-Generation Sequencing (Illumina) to validate 
identity of virus stocks.
Infection of mice
The CC strains (CC001, CC002, CC003, CC004, CC005, 
CC006, CC019, CC036, CC041, CC051, and CC053) were 
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obtained from the Systems Genetics Core Facility at the 
University of North Carolina (Welsh et al. 2012). Previous 
to their relocation to UNC, CC lines were generated and 
bred at Tel Aviv University in Israel (Iraqi et al. 2008), 
Geniad in Australia (Morahan et al. 2008), and Oak Ridge 
National Laboratory in the US (Chesler et al. 2008). Mice 
were bred in our animal facility at the HZI in Braunsch-
weig by brother–sister mating for one to eight genera-
tions depending on the respective strain and time point of 
experiments. For experimental mice, also cousin mating 
was performed. Since only a few generations of breeding 
were done, the inbreeding status is expected to be similar 
to the mice that were received from UNC (http://csbio .unc.
edu/CCsta tus/CCGen omes/#genot ypes). All mice were 
maintained under specific pathogen-free conditions and 
according to the German animal welfare law. Female, 8- to 
12-week-old mice were anesthetized by intra-peritoneal 
injection with Ketamine/Xylazine (100 mg/ml Ketamine 
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Fig. 5  (continued)
and 20 mg/ml Xylazine) in sterile sodium chloride solu-
tion. The doses were adjusted to the individual body 
weight using 200 µl/20 g body weight. Mice were then 
intra-nasally infected with 20 µl virus solution (10 FFU). 
Body weight was monitored daily as percentage of initial 
weight at the day of the infection. Mice that lost more 
than 30% of their body weight were euthanized for ethical 
reasons and were scored as dead.
RNA isolation for arrays
Blood was taken for RNA isolation at different time points 
after virus infection (days 3, 5, and 8) and mock infection 
(day 3 post sterile phosphate-buffered saline infection). 
Body weight was measured until the day of sample collec-
tion. For every treatment and day post infection (pi), 3–5 
mice per CC strain were analyzed. Blood was collected 
from anesthetized mice by retro-orbital bleeding into RNA 
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protect animal blood tubes (Qiagen), kept at room tem-
perature for at least 2 h and stored at -20 °C for long-term 
storage. Blood RNA was isolated with the RNeasy protect 
animal blood kit (Qiagen). RNA concentration was meas-
ured with the NanoDrop (Thermo Scientific).
Mouse gene expression analysis
For gene expression profiling, the Mouse Gene expres-
sion kit from Agilent was used. 200 ng of total RNA was 
transcribed into cDNA, amplified using T7 RNA polymer-
ase while incorporating cyanine 3-labeled CTP and then 
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hybridized according to the manufacturer’s protocol (Quick 
Amp, Agilent) to the Agilent 4 × 44 k Mouse V2 Design 
ID: 026655. Signal intensities were extracted from scan 
images using Feature Extraction Software v10.7.3.1. Array 
data from mouse blood samples were analyzed using the R 
software (RCoreTeam 2013). Pre-processing steps included 
background correction, quantile normalization, and anno-
tation using the MmAgilentDesign026655.db (Carlson 
2014), limma (Smyth 2004), and Agi4 × 44PreProcess 
(Gentleman et al. 2004) packages. Identification of differ-
entially expressed probe sets (DEPS) were performed with 
the LIMMA package (Smyth 2004) using BH correction for 
multiple testing (Benjamini and Hochberg 1995). Expression 
data have been deposited in the GEO expression database 
(https ://www.ncbi.nlm.nih.gov/geo/info/linki ng.html) under 
the accession number GSE110384.
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Human data sets
The following human data were downloaded from the 
GEO expression data base (http://www.ncbi.nlm.nih.gov/
geo/): GSE82050 (Tang et al. 2017), GSE52428 (Woods 
et al. 2013), GSE68310 (Zhai et al. 2015). GSE52428 
expression data matrix was  log2-transformed and quantile 
normalized and only data from volunteers with symptoms 
after the infection were used (Woods et al. 2013). This 
data set contained expression values from the blood of 
20 volunteers for 18 time points including baseline and 
pre-challenge data. The 141.5 and 165.5 h time points 
pi contained only data from 1 volunteer and were omit-
ted. GSE68310 expression data matrix, containing 
 log2-transformed values, was downloaded from GEO and 
quantile normalized. Only data from influenza-infected 
patients were used (Zhai et al. 2015). This data set con-
tained expression values from the blood of 49 patients for 
7 time points including baseline and pre-challenge data. 
GSE82050 expression data were  log2-transformed and 
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quantile normalized as described (Tang et al. 2017). This 
data set contained expression values from the blood of 
39 patients for 1 time point pi. As described in the result 
section and Table 2, only subsets that were relevant for 
our study were used. These were renamed to Woods_13, 
Zhai-15 and Tang_17, respectively, and are described in 
Table 2.
Statistics
Data were analyzed using GraphPad Prism version 5.04 
for Windows (GraphPad Software, San Diego, Califor-
nia). Mean and standard error of the mean (SEM) were 
calculated for all groups. Analysis of variance (ANOVA) 
was performed using the lm and aov functions of the R 
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software package (RCoreTeam 2013). A repeated meas-
ure ANOVA was performed using the model weight 
loss ~ strain × day from day 0 to day 5 when all mice from 
all strains were still alive. Broad sense heritability was 
determined by calculating the interclass correlation (Rut-
ledge et al. 2014): (MSB − MSW)/(MSB + (n − 1) × MSW) 
with MSB = mean square between groups, MSW = mean 
square within groups, n = mean number of mice per strain. 
Functional analysis of gene groups was performed with the 
R package clusterProfiler (Yu et al. 2012).
Discussion/conclusions
Seasonal IV infections represent a significant public health 
burden, with an estimated 500 million cases of influenza 
infection occurring globally each year (Fauci 2006). This 
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is further illustrated by that fact that in the United States 
there are approximately 200,000 IV-associated hospitali-
zations and 23,000 IV-associated deaths each year, with 
associated medical costs in excess of $10 billion dollars 
(Young-Xu et al. 2017). Therefore, given the large number 
of IV-associated hospitalizations and the significant health 
consequences of severe IV-associated disease, new methods 
are needed to rapidly assess an individual’s prognosis so that 
appropriate treatment regimens can be initiated in a timely 
manner to ensure better clinical outcomes. Transcriptional 
Fig. 6  Time course of gene 
expression changes of IFI27 
in human and mouse data sets. 
Expression values of normal-
ized  log2-transformed signal 
intensities in the blood human 
and mice in infected individuals 
versus controls are shown at the 
indicated times pi. Stripcharts 
for individual expression values 
from a GSE52428 (Woods et al. 
2013), b GSE68310 (Zhai et al. 
2015). c Histogram representing 
the difference in the expression 
changes between infected mice 
at the indicated time pi minus 
mock control values for each 
CC mouse strain. Strains are 
sorted into resistant and severe 
groups
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or proteomic analysis of readily available clinical samples, 
such as peripheral blood, represents a promising avenue 
for identifying prognostic biomarkers that can be used to 
predict patient outcome during IV infection (Herberg et al. 
2013; Huang et al. 2011; Ioannidis et al. 2012; Marion et al. 
2016; Parnell et al. 2012; Ramilo et al. 2007; Suarez et al. 
2015; Tang et al. 2017; Thach et al. 2005; Tsalik et al. 2016; 
Woods et al. 2013; Zaas et al. 2009; Zhai et al. 2015). Due to 
difficulties associated with performing follow-up studies in 
Fig. 7  Time course of gene 
expression changes of IRF7 in 
human and mouse data sets. 
Expression values of normal-
ized  log2-transformed signal 
intensities in the blood human 
and mice in infected individuals 
versus controls are shown at the 
indicated times pi. Stripcharts 
for individual expression values 
from a GSE52428 (Woods et al. 
2013), b GSE68310 (Zhai et al. 
2015). c Histogram representing 
the difference in the expression 
changes between infected mice 
at the indicated time pi minus 
mock control values for each 
CC mouse strain. Strains are 
sorted into resistant and severe 
groups
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humans, the validation and mechanistic evaluation of these 
bio-signatures often relies on animal models of IV disease.
However, the value of experimental models, especially 
the mouse, has recently been questioned in the scientific 
literature and in public (Seok et al. 2013). These results have 
been challenged later (Takao and Miyakawa 2014). Here, we 
addressed two important aspects that are often ignored in 
cross-species mouse/human comparisons: the influence of 
genetic background and the choice of the correct tissues. Our 
results clearly demonstrate that by comparing the appropri-
ate tissue types (peripheral blood), and accounting for the 
impact of genetic variation on IV-associated gene expres-
sion through the use of genetically complex mouse panels, 
the bio-signatures identified in the mouse show good con-
cordance with human studies. Therefore, these experimental 
animal systems represent an important set of tools for the 
identification, mechanistic analysis, and/or validation of bio-
signatures of IV-induced disease.
IV infection of inbred mouse strains represents one of 
the most commonly used systems for studying IV disease 
pathogenesis and identifying host factors associated with 
virus-induced disease outcome (Kollmus et al. 2014). This is 
due to a wide range of factors, including the reproducibility 
of standard inbred strains, such as C57BL/6 mice, the ability 
to study the role of specific genes in IV disease pathogenesis 
through gene knockout animals, and the availability of an 
extensive toolkit of reagents for quantifying immune and 
other host responses in the mouse. However, as noted above, 
mouse models have recently come under attack due to ques-
tions about whether the mouse can reproduce disease states 
and gene expression profiles observed in humans (Seok et al. 
2013). While the studies of Seok et al. raise concerns about 
mouse models, it is important to note that their study did not 
account for the impact of genetic diversity on differential 
findings in mice and humans. Therefore, our finding that 
studying a population of genetically diverse mouse strains, 
such as the CC, results in IV-induced transcriptional signa-
tures that better reproduce human biomarkers has important 
implications not just for IV but also the study of other patho-
gens. Similar to the CC founders (Ferris et al. 2013; Leist 
et al. 2016), CC mice exhibit a broad range of phenotypes 
following infection with other pathogens (Gralinski et al. 
2015; Rasmussen et al. 2014) which suggests that using the 
CC to identify bio-signatures for other pathogens may also 
provide greater concordance with human studies than is seen 
with existing mouse models.
Another important aspect of our studies is the direct 
comparison of transcriptional responses in the peripheral 
blood of mice and humans. Our analysis of IV-induced 
responses between lung and peripheral blood suggests 
that gene expression patterns and kinetics are different 
between these tissues which in addition to the effects of 
genetic diversity discussed above, likely contribute to the 
discordance between mouse and human gene expression 
studies. Therefore, it will be important to directly compare 
the same tissues in mice and humans when performing 
marker validation studies. Furthermore, our results illus-
trate the importance of performing carefully controlled 
gene expression studies in mice, since the ability to assess 
baseline gene expression in mock-infected animals pro-
vides an opportunity to specifically identify those genes 
which are differentially expressed due to IV infection.
Our studies address an important public health issue 
since there are no good biomarkers to distinguish bacterial 
from viral respiratory infections and for predicting severe 
course of influenza disease. Thus, transcripts that change 
in mice may represent potential biomarkers that need to 
be validated in humans. Therefore, the use of appropri-
ately diverse mouse models, combined with assessment of 
gene expression differences in the appropriate tissue types 
(e.g., peripheral blood), provides an excellent system for 
identifying and confirming the most biologically relevant 
biomarkers for differentiating between IV versus other 
infections or predicting IV disease outcome.
Our analysis of mouse–human transcriptome changes 
in the peripheral blood demonstrated that the mouse rep-
resents a highly valuable model for validation and dis-
covery of changes in single genes from human patients. 
At the level of single genes, the mouse model very well 
reproduces the responses observed in human cohorts, for 
differential expression between infected and non-infected 
groups and with respect to the time course of expression. 
Both IFI27 and IRF7 are up-regulated after IV infection 
in mice and humans, and these genes therefore represent 
good biomarker candidates for respiratory viral infections. 
Indeed, we have already followed up on this aspect and 
confirmed IFI27 in an independent cohort in humans and 
shown that dendritic cells (DCs) activate expression of 
IFI27 after exposure to IV.
In summary, gene expression changes at the single gene 
level demonstrate high reproducibility across species. Thus, 
results in humans can be validated in mice and vice versa. 
Therefore, well-designed cross-species studies are highly 
informative, in our opinion essential, for the development 
of better treatments and diagnosis in humans.
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